This invention is directed to novel (N-substituted)indole ICE-inhibitor compounds. The invention is also directed to pharmaceutical compositions of such indole compounds, plus the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

Cette invention est dirigée vers le roman (composés de N-substituted)indole ICE-inhibitor. L'invention est également dirigée vers les compositions pharmaceutiques de tels composés d'indol, plus l'utilisation de telles compositions dans le traitement des patients les maladies inflammatoires, autoimmunes et neurodegenerative de souffrance, pour la prévention des dommages ischémiques, et pour la conservation des organes qui doivent subir un procédé de transplantation.

 
Web www.patentalert.com

< Human bad polypeptides, encoding nucleic acids and methods of use

< MCH4 and MCH5, apoptotic proteases

> Inhibitors of the ICE/ced-3 family of cysteine proteases

> Method of inhibiting NADPH oxidase

~ 00064